Jupiter Asset Management Ltd. Has $268,000 Stake in UnitedHealth Group Incorporated $UNH

Jupiter Asset Management Ltd. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 99.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 860 shares of the healthcare conglomerate’s stock after selling 130,581 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in UnitedHealth Group were worth $268,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Markel Group Inc. lifted its stake in UnitedHealth Group by 4.9% during the first quarter. Markel Group Inc. now owns 28,014 shares of the healthcare conglomerate’s stock worth $14,672,000 after purchasing an additional 1,300 shares during the last quarter. Independent Wealth Network Inc. increased its stake in shares of UnitedHealth Group by 8.4% in the 1st quarter. Independent Wealth Network Inc. now owns 503 shares of the healthcare conglomerate’s stock valued at $263,000 after purchasing an additional 39 shares during the last quarter. Finally, Jennison Associates LLC lifted its position in shares of UnitedHealth Group by 105.4% during the 1st quarter. Jennison Associates LLC now owns 502,076 shares of the healthcare conglomerate’s stock worth $262,962,000 after buying an additional 257,599 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.3%

Shares of NYSE:UNH opened at $321.44 on Friday. The business has a fifty day simple moving average of $347.65 and a 200 day simple moving average of $320.06. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The firm has a market cap of $291.17 billion, a P/E ratio of 16.78, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company earned $7.15 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

Several brokerages have commented on UNH. TD Cowen boosted their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. KeyCorp boosted their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, Piper Sandler lowered their target price on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $397.12.

Get Our Latest Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.